Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07422506

A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
580 (estimated)
Sponsor
The Third Xiangya Hospital of Central South University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

At present, there is no unified standard for the treatment of missed abortion in clinical practice. This study intends to collect clinical data of this type of disease to compare the efficacy of different treatments, and on this basis, presuppose the synergistic effect of different doses of estrogen in the process of drug induction, conduct statistical analysis of the efficacy, evaluate whether the treatment plan can achieve the therapeutic effect while reducing the occurrence of complications, and provide an effective basis for the subsequent clinical treatment of missed abortion. This study is divided into two parts. The first part is a retrospective analysis to explore the differences between missed abortion surgery and drug treatment, clinical efficacy and reproductive outcomes; the second part is a prospective study to explore the effects of different doses of estrogen combined with surgery or drug abortion on the efficacy of missed abortion in early pregnancy, and explore the best clinical treatment method for missed abortion.

Conditions

Interventions

TypeNameDescription
DRUGControl groupNo estrogen supplementation
DRUGConventional dose of estrogen1 day after medical abortion, give oral estradiol valerate, 1 mg Bid, for 21 days, and add dydrogesterone 10 mg Bid for the next 7 days. Take it in a cycle starting from the 5th day of the next menstruation for a total of 2 cycles.
DRUGHigh-dose estrogen1 day after abortion, give oral estradiol valerate, 2 mg Bid, for 21 days, and add dydrogesterone 10 mg Bid for the next 7 days. Take it in a cycle starting from the 5th day of the next menstruation for a total of 2 cycles.

Timeline

Start date
2024-01-01
Primary completion
2030-01-01
Completion
2035-01-01
First posted
2026-02-20
Last updated
2026-02-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07422506. Inclusion in this directory is not an endorsement.